BioStratum

About:

BioStratum develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications.

Top Investors: HealthCap, BankInvest, Equity Resources Group, Liftaeknisjodurinn HF

Description:

BioStratum, Inc. develops and commercializes therapeutic agents for the treatment of diabetes and diabetic complications. Its products include Pyridorin, a small molecule drug for the treatment of diabetic kidney disease; and pre-clinical compounds that treat diabetic complications and cancer. The company was founded in 1994 and is headquartered in Durham, North Carolina.

Total Funding Amount:

$10.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Durham, North Carolina, United States

Founded Date:

1994-01-01

Founders:

Karl Tryggvason

Number of Employees:

1-10

Last Funding Date:

2011-08-19

IPO Status:

Private

Industries: